VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- October 03, 2006 -- enGene, Inc., a privately held biotechnology company developing an innovative approach for the treatment of diabetes called GEMS™-Insulin, announced today that Dr. Christopher J. Rhodes and Dr. Imre Kovesdi have joined the company as Scientific Advisors. The addition of Drs. Rhodes and Kovesdi further bolsters the Company’s expertise in the areas of diabetes and gene therapy.
